The National Society of Pharmaceutical Sales Trainers recently appointed three new people to their board of directors. Two positions were created for industry partners and one position was filled due to a vacancy.
The National Society of Pharmaceutical Sales Trainers recently appointed three new people to their board of directors. Two positions were created for industry partners and one position was filled due to a vacancy.
Industry Partners are the various training and meeting vendors that work closely with pharmaceutical sales training departments.
Jim Dutton, the president of the Certified Medical Representative Institute, Inc., Roanoke, VA, accepted one of the industry partners board positions. Dutton and CMR have been active supporters of NSPST and regular participants in the NSPST national conventions for many years.
"I am extremely honored to be elected to the NSPST board of directors as one of two representatives of the industry partners group," Dutton said in response to his election to the NSPST board.
"I think the Society has sent a clear message to all industry partners that says that NSPST recognizes the important role industry partners have played over the years to help make the organization more successful. They value our input and support. They believe we can have a positive impact on their plans for the future."
Cynthia Kolodzinski, the director for training and development for Medical Education Systems, Inc., Philadelphia, also accepted an industry partners board position.
Medical Education Systems, Inc.'s support for NSPST and Kolodzinski's previous association with the NSPST board will contribute to the value of her presence on the NSPST board.
"My experience from the pharmaceutical manufacturer's side provided me with the opportunity to work closely with all of the industry partners," said Kolodzinski. "These relationships will allow me to be an effective representative of the industry partners as we support the goals of NSPST. My new responsibilities as an industry partner have helped me understand what industry partners are up against when they consult with the manufacturers."
According to Jim Sullivan, the account manager for the NSPST, this partnership furthers the collaboration between consultants/vendors and training professionals. NSPST members will be more likely to work with industry partner companies.
"Both Jim Dutton and Cynthia Kolodzinski know what is 'hot' in training," said Sullivan. "They can assist us in numerous ways, both today and into the future. They know what is going on across the industry in a number of different companies and can advise us on what is on the cutting edge of pharmaceutical sales training and industry trends."
Kimberly Farrell, of Roche Laboratories, assumed the position of director of special projects that was recently vacated. Farrell has been a workshop presenter at past national conventions and brings excellent training and field experience to the NSPST board. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.